NCCR-Synapsy

The Synaptic Bases of Mental Diseases

home

SynapsyLogofdtranspweb

NCCR-SYNAPSY The Synaptic Bases of Mental Diseases

Researchers and psychiatrists of the Swiss National Centre Competence in Research NCCR-SYNAPSY have joined forces to study the biological basis of psychiatric disorders.
In order to offer patients new perspectives of a cure and a higher quality of life, this innovative union between psychiatry and neuroscience is seeking to better understand the origins of mental disorders, and thus settle upon better diagnosis and treatments.

SYNAPSY LATEST NEWS

Is schizophrenia the cost of a poor brain optimisation?
22q11 deletion syndrome

Is schizophrenia the cost of a poor brain optimisation?

Patients with 22q11.2 deletion syndrome have a high risk of developing schizophrenia. According to a recent study by neuroscientists from...
Read More
Why making the right choice is difficult when you’re stressed
Mood disorders

Why making the right choice is difficult when you’re stressed

Study by members of Synapsy, the Swiss National Centre of Competence in Research in psychiatric disorders, explains why we make...
Read More
Invitation for entries for the Research prize of the Swiss Brain League
Prize

Invitation for entries for the Research prize of the Swiss Brain League

Every two years, the Swiss Brain League awards a prize of CHF 20,000 to a Swiss research group in recognition...
Read More
Has the ideal target for treating anxiety been discovered?
Mood disorders

Has the ideal target for treating anxiety been discovered?

Synapsy’s neuroscientists based at EPFL have identified a cell molecule that can regulate anxiety and prevent depression. Located at the...
Read More
Poor wiring in the centre of the brain leads to psychosis
22q11 deletion syndrome

Poor wiring in the centre of the brain leads to psychosis

Psychosis is linked to abnormalities in brain development. A team from the Synapsy National Centre of Competences in Research has...
Read More
Best wishes for 2021
NEWS

Best wishes for 2021

The Management Team wishes You all the Best for the New Year!
Read More
From academia to entrepreneurship – seizing an opportunity to make a significant contribution to the treatment of neurological disorders
Mood disorders Newsletter

From academia to entrepreneurship – seizing an opportunity to make a significant contribution to the treatment of neurological disorders

We spoke with Charles Finsterwald, PhD, Chief Scientific Officer and co-founder of the start-up Gliapharm about his career path and...
Read More
Lactate, a prospect for the treatment of depression
Mood disorders Newsletter

Lactate, a prospect for the treatment of depression

According to WHO, more than 264 million people in the world suffer from depression, a disorder that has a major...
Read More
Holography and cellular reprogramming in the quest for biomarkers
Mood disorders Newsletter

Holography and cellular reprogramming in the quest for biomarkers

Bipolar disorders affect some 2% of the population. Patients present a wide variety of clinical symptoms of which many can...
Read More

Below, our 3’04” presentation video (English) – Version française >

Home Institutions :

Partners :

SNSFFMIUNIBASHUGCHUV

Collaborations :